TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,777 | +2.4% | 16,507 | +37.6% | 0.00% | – |
| Q2 2023 | $5,640 | -74.6% | 12,000 | -62.8% | 0.00% | – |
| Q1 2023 | $22,188 | -41.5% | 32,253 | -10.8% | 0.00% | – |
| Q4 2022 | $37,958 | -87.8% | 36,150 | -52.8% | 0.00% | – |
| Q3 2022 | $311,000 | -60.9% | 76,511 | -45.7% | 0.00% | – |
| Q2 2022 | $796,000 | -56.3% | 140,948 | -51.2% | 0.00% | – |
| Q1 2022 | $1,821,000 | -79.0% | 288,585 | -70.5% | 0.00% | – |
| Q4 2021 | $8,684,000 | +258.5% | 979,152 | +212.1% | 0.00% | – |
| Q3 2021 | $2,422,000 | +9.6% | 313,692 | +36.5% | 0.00% | – |
| Q2 2021 | $2,209,000 | -44.7% | 229,845 | -21.8% | 0.00% | – |
| Q1 2021 | $3,991,000 | -34.3% | 294,103 | -30.6% | 0.00% | – |
| Q4 2020 | $6,070,000 | +105.2% | 423,900 | +164.6% | 0.00% | – |
| Q3 2020 | $2,958,000 | – | 160,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |